A 55,000-60,000 Mr receptor protein for urokinase-type plasminogen activator. Identification in human tumor cell

L S Nielsen1, G M Kellerman, N Behrendt

  • 1Finsen Laboratory, Rigshospitalet, Copenhagen, Denmark.

Insights

The urokinase-type plasminogen activator receptor (u-PA-R) binds to the amino-terminal fragment (ATF) of urokinase-type plasminogen activator (u-PA). This study identifies and characterizes u-PA-R, a key protein in cell surface interactions.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Molecular Biology

Background:

  • Urokinase-type plasminogen activator (u-PA) plays a role in cell surface interactions.
  • The u-PA receptor (u-PA-R) mediates these interactions.
  • Understanding u-PA-R is crucial for studying cellular processes.

Purpose of the Study:

  • To investigate the binding characteristics of the amino-terminal fragment (ATF) of u-PA.
  • To identify and characterize the u-PA receptor (u-PA-R) on human tumor cell lines.
  • To determine the molecular properties of u-PA-R.

Main Methods:

  • Cell surface binding assays using iodinated ATF.
  • Cross-linking of ATF to cell surface proteins.
  • Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and autoradiography.
  • Affinity chromatography for protein purification.

Main Results:

  • Iodinated ATF specifically bound to the cell surface of human tumor cell lines.
  • A 55,000-60,000 Mr u-PA receptor protein (u-PA-R) was identified.
  • u-PA-R consists of a single polypeptide chain and exhibits varying affinities for concanavalin A.
  • Purified u-PA-R specifically bound u-PA, proenzyme u-PA, and ATF.

Conclusions:

  • The u-PA receptor (u-PA-R) is a cell surface protein that binds the amino-terminal fragment (ATF) of urokinase-type plasminogen activator (u-PA).
  • u-PA-R was purified and characterized, revealing its molecular structure and binding specificities.
  • These findings contribute to the understanding of u-PA mediated cell signaling pathways.

Related Concept Videos